As scientists make great strides in their research on psychedelic therapies for depression, PTSD, OCD, addiction and other conditions, new ways to deliver the drugs are also emerging from laboratories. Oregon company Silo Wellness announced the availability of a new nasal spray for psilocybin, the psychoactive ingredient in magic mushrooms. The company conducted their research and formulated the product in Jamaica where psilocybin is legal. From the Silo Wellness press release:
The key to the nasal spray is that it bypasses the gut, going directly to the bloodstream through the nasal mucus membranes and eventually the liver for metabolizing. “Many psilocybin patients, particularly women, complain of upset stomach or vomiting when taking high-doses of mushrooms,” Board Advisor and Silo Wellness investor Becky Rotterman, a Missouri pharmacist, stated. “We want to bring this wonderful natural medicine first to Oregon and then the flyover states – to those who would be afraid to eat a handful of fungi and who feel more comfortable seeing their medicine in a familiar delivery modality, such as a metered-dose nasal spray...."
Regarding the expansion of legalization efforts, Arnold explained that “this is the sort of product that activists can discuss with their legislators to show that safe consumption is possible within a legal framework.”
“With proof of concept in hand, we are taking pre-orders and entertaining licensing proposals for research abroad and manufacturing for the product in advance of jurisdictions coming online legally, similar to Oregon’s proposed medical-marijuana-like psilocybin initiative,” COO Scott Slay, of Eugene, Oregon stated. “
For years, those who have been following and even participating in the benefits of psilocybin have understood and read about the ability of magic mushrooms to combat a number of ailments. From helping the terminally ill come to grips with their own mortality to treating PTSD and depression — psilocybin has a wide range of benefits. Up until recently, however, the government has ignored these benefits and prosecuted those for seeking them out. All that is now changing though, and the US Food and Drug Administration (FDA) has just granted Breakthrough Therapy status to psilocybin for its ability to clinically treat depression.
In every single state in the country, most psychedelic drugs, including ones found to be extreme safe, will get you kidnapped, caged, or killed. For decades, the government has violently and outright disgracefully sought to throw people in cages for possessing these substances. However, as TFTP has stated on numerous occasions—no army can stop an idea whose time has come. And, the time for psychedelics is upon us.
‘People on antidepressants long-term say they feel blunted, with psychedelic therapy it’s the opposite, they talk about an emotional release, a reconnection’
Yesterday, Oakland became the second U.S. city to decriminalize psilocybin despite federal prohibition. Passage of the resolution takes a first step toward nullifying federal prohibition in practice and effect. The Oakland city council voted unanimously to decriminalize the adult use and possession of “magic mushrooms” containing psilocybin along with other entheogenic, or psychoactive, plants and fungi.
Nearly seven years ago, Colorado citizens—tired of the war on drugs and wise to the near-limitless benefits of cannabis—made US history by voting to legalize recreational marijuana. Now, this state has once again placed themselves on the right side of history as they voted this month to decriminalize magic mushrooms. But this was just the beginning and their momentum is spreading—faster and stronger, toward decriminalizing all plant-based psychedelics. Now, a major city in California is following suit, but not just with psilocybin—Oakland is calling for decriminalization of other psychedelics like mescaline cacti, ayahuasca and ibogaine.
The measure, which was behind in early returns on election night but edged closer with each new batch of ballots counted, ended up pulling ahead with a 51 percent to 49 percent margin in the final unofficial results posted on Wednesday afternoon.
Terminally ill patients will be treated with ‘magic mushrooms’ at a hospital in Melbourne, Australia, as part of a new medical trial aimed at reducing anxiety in dying people. It took more than a year for the trial at St Vincent’s Hospital to secure approval from the ethics committee and federal and state authorities. It’s now due to begin in April with 30 patients.
This week, it was announced that a startup called Compass Pathways has received approval from The Food and Drug Administration to develop treatments for depression, and possibly even pharmaceuticals, with psilocybin, the active ingredient in psychedelic “magic mushrooms.”
Much like the carefully orchestrated de-legalization of cannabis during the 1930’s, there was a powerful decades-long misleading campaign against psilocybin mushrooms which caused a deep-rooted fear and a subsequent public rejection of this substance.
Our IP Address: